Fulgent Genetics Follow Verify

www.fulgentgenetics.com
Fulgent Genetics
Type	Public
Industry	Biotechnology
Founded	2011
Headquarters	Temple City, California 91780 United States
Key people	Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO)

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

• Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
• College of American Pathologists (CAP) Accreditation 2017
• California Clinical Laboratory License 2016
• Florida Clinical Laboratory License 2016 - 2018
• Pennsylvania Clinical Laboratory Permit 2016-2017
• Maryland Medical Laboratory License 2015-2016

Top 5 Recent Tweets

Date	Author	Comment
May 16, 2022	algobotnews	Fulgent Genetics management to meet with Piper Sandler $FLGT
May 16, 2022	fundamentalsbot	Fulgent Genetics, Inc's quarterly revenue growth rate YoY of -10.90% ranked 3463 out of 5730 companies in our datab… https://t.co/vPfCbPkaUV
May 03, 2022	The_Real_Fly	Fulgent Genetics beats by $1.22, beats on revs; lowers FY22 EPS guidance below single analyst estimate, raises reve… https://t.co/E5ea0q7Ael

Top 5 Lifetime News Headlines

Top Authors

• Archana Sinha
• View all authors

Verification history

• 2,023 days ago


• View all verifications